UKVIA Expresses Disappointment Over UK Tobacco and E-cigarette Act Hearing

Jan.13
UKVIA Expresses Disappointment Over UK Tobacco and E-cigarette Act Hearing
UKVIA expresses disappointment over exclusion from tobacco and e-cigarette bill hearing, warns of potential impact on smoking cessation efforts.

On January 8th, the UK Vaping Industry Association (UKVIA) announced on its official website that it was disappointed that industry representatives and adult advocates for smoking cessation through e-cigarettes were not invited to speak at the January 7th hearing for the Tobacco and E-Cigarette Act. The Act could potentially impact the effectiveness of e-cigarettes as a smoking cessation tool and may prevent smokers from switching to e-cigarettes, or even lead adult e-cigarette users back to traditional cigarettes or the black market.


On January 7th, the UK Parliament's Public Bill Committee held a hearing on the bill, with several government Chief Medical Officers and heads of health organizations giving testimony.


Hazel Cheeseman, CEO of Action on Smoking and Health in the UK, believes that the bill is an important step in reducing smoking among the next generation and helping smokers quit. However, she emphasizes that the government still needs to invest in supporting smokers to quit, highlighting the importance of e-cigarettes as a cessation tool. She supports the bill's restrictions on e-cigarette marketing to protect children, while ensuring that adult smokers have access to e-cigarettes.


The Chief Medical Officer of Wales, Francis Atherton, has emphasized that the tobacco industry has been targeting children in their marketing efforts. He supports legislation aligning e-cigarette regulations with tobacco regulations to reduce youth e-cigarette usage.


The Chief Medical Officer of Scotland, Gregor Ian Smith, emphasized the importance of the bill in reducing the burden of tobacco-related diseases, supporting the bill to unify tobacco and e-cigarette regulations across the four regions to enhance the dissemination of public health information.


Ian Walker, the Policy, Information and Communications Director of Cancer Research UK, believes that the legislation is crucial in reducing the number of cancer cases caused by smoking. He emphasizes the flexibility of the legislation, stating that it can be adjusted according to new evidence and emerging trends in the tobacco industry.


UKVIA stated that the legal e-cigarette industry has always been committed to helping adults quit smoking and shares the goal of a smoke-free future with society. Consumers whose lives have been changed by e-cigarettes should have the opportunity to speak at the meeting on that day.


UKVIA will be holding an event at Parliament on January 8th to present industry perspectives to government officials, with a focus on discussing the Tobacco and e-cigarette Act, including potential implementation of a retail licensing scheme.


Click to view the full transcript of the hearing.


Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.